ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Health Canada clears Appili Therapeutics for new phase 3 trial to assess Avigan to prevent Covid-19
November 27, 2020Appili Therapeutics, a biopharmaceutical company focused on anti-infective drug development, announced initiation of its Phase 3 Post Exposure Prophylaxis for COVID-19 (PEPCO) study to evaluate Avigan tablets (favipiravir) in the prevention of Covid-19.
Pharma Sources Insight January 2025
